Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma
Key Points
Consolidation reduced-dose whole-brain radiation therapy shows efficacy in patients with primary central nervous system lymphoma.
Patients receiving response-adapted boost experienced enhanced therapeutic effects and reduced side effects.
This analysis utilized advanced imaging techniques to tailor radiation treatment regimens in older populations.
Findings support the potential for optimized radiation protocols to improve care in this vulnerable group.
Consolidation reduced-dose whole-brain radiation therapy with response-adapted boost in older patients with newly diagnosed primary central nervous system lymphoma | Synapse
Also Consider
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: